Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations

NCT02596100 is registered in ClinicalTrials.gov with Portola Pharmaceuticals as lead sponsor.

NCT NCT02596100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02596100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Bioequivalence Study to Compare the Pharmacokinetics of Two Betrixaban Formulations
Lead sponsor
Portola Pharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2015
Completion date
November 30, 2015
Enrollment
52 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy